Radiofrequency Ablation For Recurrent Parathyroid Carcinoma
This is not medical advice. AI-assisted translation — inaccuracies may occur. Always verify the original and consult your oncologist before taking any steps.
About the trial
The study will be an effectiveness study. The study will include enrollment of a total of 20 patients with at least one PC lesion for ultrasound guided RFA to PC recurrence in the neck to assess the effectiveness in reducing patient's hypercalcemia. Patients will have surgically proven PC from prior parathyroidectomy and suspicious PC visible on ultrasound and request for treatment for uncontrolled hypercalcemia (Figure 1).
Original English text from ClinicalTrials.gov
Who can (and can't) join
✓ Qualifies
- •Wiek powyżej 18 lat i pacjent nie może być operowany lub odmawia operacji
- •Stan zdrowia pozwala na znieczulenie lokalne i sedację
- •Pacjent zdolny do zrozumienia i wyrażenia zgody na uczestnictwo
- •Potwierdzony rak przytarczyc poprzednia operacją i badaniem histopatologicznym
- •Widoczny na ultrasonografii nawrót guza lub zmiana w szyi
- •Guza bez dużych złogów wapnia i bez cystycznych zmian wewnątrz
- •Pacjent nie przyjmuje leku Cinacalcet
Simplified criteria — AI translation
Trial details
- Minimum age
- 18 Years
- Last updated (source)
- October 7, 2026
- Sex
- No restrictions
Therapies / drugs in trial
Locations (1)
UT MD Anderson
Houston, United States
Trial contact
Thinh Vu, MD
Contact information from ClinicalTrials.gov. Contact in English.
Share this trial
Data from ClinicalTrials.gov. AI-assisted translation, last sync: 10/8/2026.
You can help another person
We fund the Radar, this site, and the development of our Grosz dla Życia fundraising platform from donations and our own resources. Every contribution, even a small one, really helps.